Hanmi Pharm Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Jae-Hyun Park
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 1.3yrs |
CEO ownership | 0.005% |
Management average tenure | no data |
Board average tenure | no data |
Recent management updates
Recent updates
Hanmi Pharm. Co., Ltd.'s (KRX:128940) Share Price Not Quite Adding Up
Apr 22Calculating The Intrinsic Value Of Hanmi Pharm. Co., Ltd. (KRX:128940)
Mar 15Hanmi Pharm (KRX:128940) Use Of Debt Could Be Considered Risky
Feb 16What Percentage Of Hanmi Pharm. Co., Ltd. (KRX:128940) Shares Do Insiders Own?
Jan 17Hanmi Pharm's (KRX:128940) Stock Price Has Reduced 48% In The Past Five Years
Dec 22Hanmi Pharm. Co., Ltd. (KRX:128940) Shares Could Be 22% Below Their Intrinsic Value Estimate
Nov 24CEO
Jae-Hyun Park (55 yo)
1.3yrs
Tenure
Mr. Jae-Hyun Park serves as Head of Quality Management Team of Hanmi Pharmaceutical Co., Ltd. He is Chief Executive Officer at Hanmi Pharm. Co., Ltd since 2023.Mr. Park serves as a Director of Paik Kwang...